← Leaderboards
Jae Hyuk Yoo
University Of Utah
$1,563,438
Attributed
$1,563,438
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $528.5K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,563,438 · 3
By mechanism
R00$741,981 · 1
P20$561,809 · 1
K99$259,648 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Allie H. Grossmann$3,010,476
- Shannon J Odelberg$4,968,511
- Dean Yaw Li$21,127,919
- Guy A. Zimmerman$14,469,264
- Arthur R Brothman$323,156
Others in their field
Other Emerging Leaders on “Map Kinase Gene”
- Yuichi Shimada · Columbia University Health Sciences$5,671,179
- Timothy R Siegert · Allyx Biosciences, Inc.$5,367,450
- Shihui Liu · University Of Pittsburgh At Pittsburgh$4,515,004
- James T Bennett · Seattle Children'S Hospital$4,447,662
- Inma Cobos · University Of California Los Angeles$3,472,658
- Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai$3,448,721
Research focus
Map Kinase GeneOncogenicGrowthMalignant NeoplasmsMouse ModelNeoplastic CellCytoplasmic VesiclesGenetic TranscriptionInsightKnock-DownMelanomaMonomeric Gtp-Binding ProteinsMutationNeoplasm MetastasisBeta CateninCell MembraneBindingCell NucleusHuman ModelCellsIn VitroIn VivoMediatingPathway Interactions
Grant awards (7)
Targeting ASAP1-Controlled Signal Pathways to Inhibit Uveal Melanoma Metastasis$280,904
P20 · FY2024 · GM · contact PI
Targeting ASAP1-Controlled Signal Pathways to Inhibit Uveal Melanoma Metastasis$280,905
P20 · FY2023 · GM · contact PI
ARF6 function in cancers driven by RAS hyperactivation$247,551
R00 · FY2023 · CA · contact PI
ARF6 function in cancers driven by RAS hyperactivation$247,551
R00 · FY2022 · CA · contact PI
ARF6 function in cancers driven by RAS hyperactivation$246,879
R00 · FY2021 · CA · contact PI
ARF6 function in cancers driven by RAS hyperactivation$129,824
K99 · FY2019 · CA · contact PI
ARF6 function in cancers driven by RAS hyperactivation$129,824
K99 · FY2018 · CA · contact PI